|
- (P-1248) Phase 2 Pharmacokinetics and Anti-Drug Antibody Re. . .
<b>Background: < b><p class="MsoNormal" style="margin-bottom: 0cm; line-height: 115%;"><span lang="EN-GB" style="font-family: 'Arial',sans-serif; mso-bidi-font-family
- Alice Han, MD - idweek2025. eventscribe. net
Alice Han, MD is a senior partner at Metro Infectious Disease Consultants (MIDC) With over 14 years of experience in private practice, Dr Han has demonstrated her expertise in both patient and physician management Accordingly, she serves on the Medical Executive Committee for MIDC which directs strategic planning and advises senior management Alice has been a champion of individual and
- (P-2183) In Vitro 425 nm Light Biomodulation Reduces Influe. . .
<b>Background: < b><p class="MsoNormal" style="text-align: justify;">The RD-X19 is an investigational medical device that targets 420 – 430 nm light to the
- The COVID Countdown The Latest in Safeguarding Pro. . .
COVID-19 remains a significant concern for individuals with immunocompromising conditions and those of older age This CME-certified educational initiative aims to increase clinician knowledge and confidence regarding the latest clinical developments in COVID-19 post-exposure prophylaxis, particularly for vulnerable populations at risk of severe outcomes A 30-minute social media event will
- Paul Spearman, MD - idweek2025. eventscribe. net
Paul Spearman, MD is Professor of Infectious Diseases and Vice Chair for Clinical Translational Research in the Department of Pediatrics at Cincinnati Children’s Hospital Medical Center Dr Spearman has previously served as Division Chief for Infectious Diseases at Emory University and at Cincinnati Children’s Hospital He is Past President of the Pediatric Infectious Diseases
- Nicholas P. Marshall, MD, FAAP - idweek2025. eventscribe. net
Nicholas Marshall is a Pediatric Infectious Diseases and Clinical Informatics fellow at Stanford University He completed his pediatrics residency and chief residency at Cleveland Clinic, where he also served as a hospitalist and primary care physician His academic work bridges infectious diseases and data science, with a focus on stewardship and the development of decision support tools to
- (P-101) A Phase 3 International, Multi-Center, Randomized,. . .
<b>Background: < b>Catheter-related or central line-associated bloodstream infection (CRBSI CLABSI) causes substantial morbidity and mortality Managing CRBSI CLABSI often involves removing the infected central venous catheter (CVC) and inserting a new one at a different vascular site Currently, no adjunct antimicrobial lock therapy (in combination with systemic antibiotics) has been FDA
- (P-1385) Real World Side Effect Profile of Bedaquiline: An . . .
<b>Background< b>: <p dir="ltr" style="line-height: 1 38; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 11pt; font-family: Arial,sans-serif; color
|
|
|